Fundraising FoxMB Venture Partners — 2013 Investments
1 investments dated 2013 · listed companies and verified rows first · show all
Hapten Scienceshaptensciences.comMay 2013SEC filingmedium confidence
Hapten Sciences develops early-stage pharmaceutical products focused on dermatological health, with its lead candidate PDC-APB in clinical development as a preventive immunotherapy for contact dermatitis caused by exposure to poisonous plants.
BiotechHealthtechMedical DevicesMemphis, US
Raymond J Hage(Executive Officer, Director, Promoter)
BoardGary Prosterman(Executive Officer, Director, Promoter)Stephen I. Bandak(Director)
Board seatGary Stevenson· per SEC Form D · $1.2M raise · filed Feb 2017
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.